<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10202034" created="18/05/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10202034</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T64" sem="Protein_molecule">Extracellular-regulated kinase 1/2</term>, <term id="T2" lex="Jun_N-terminal_kinase" sem="Protein_molecule">Jun N-terminal kinase</term>, and <term id="T3" lex="c-Jun" sem="Protein_molecule">c-Jun</term> are involved in <term id="T5" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>-dependent <term id="T1" sem="Other"><term id="T6" lex="IL-6" sem="Protein_molecule">IL-6</term> expression</term> in <term id="T4" sem="Cell_natural"><term id="T65" sem="Multicellular_organism_natural">human</term> monocytes</term>.</sentence>
<event id="E1">
<type class="Gene_expression"/>
<theme idref="T6"/>
<clue>Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 <clueType>expression</clueType> in human monocytes.</clue>
</event>
<event id="E2">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="T5"/>
<clue>Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-<clueType>dependent</clueType> IL-6 expression <clueLoc>in human monocytes</clueLoc>.</clue>
</event>
<event id="E3">
<type class="Correlation"/>
<theme idref="T64"/>
<theme idref="E2"/>
<clue>Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are <clueType>involved</clueType> <linkTheme>in</linkTheme> NF-kappa B-dependent IL-6 expression in human monocytes.</clue>
</event>
<event id="E4">
<type class="Correlation"/>
<theme idref="T2"/>
<theme idref="E2"/>
<clue>Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are <clueType>involved</clueType> <linkTheme>in</linkTheme> NF-kappa B-dependent IL-6 expression in human monocytes.</clue>
</event>
<event id="E5">
<type class="Correlation"/>
<theme idref="T3"/>
<theme idref="E2"/>
<clue>Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are <clueType>involved</clueType> <linkTheme>in</linkTheme> NF-kappa B-dependent IL-6 expression in human monocytes.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">In the present study we investigated the possible involvement of the <term id="T7" lex="mitogen-activated_protein_kinase_family" sem="Protein_family_or_group">mitogen-activated protein kinase family</term> members <term id="T8" lex="extracellular-regulated_kinase_1/2" sem="Protein_molecule">extracellular-regulated kinase 1/2</term> (<term id="T9" lex="ERK1/2" sem="Protein_molecule">ERK1/2</term>) and <term id="T10" sem="Protein_molecule">c-Jun N-terminal kinase</term> (<term id="T11" lex="JNK" sem="Protein_molecule">JNK</term>) in mediating <term id="T120" sem="Other"><term id="T12" lex="IL-6" sem="Protein_molecule">IL-6</term> gene expression</term> in <term id="T14" lex="human_monocyte" sem="Cell_natural">human monocytes</term>, in particular their role in enhancing <term id="T15" lex="NF-kappa_B_activity" sem="Other"><term id="T16" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activity</term>.</sentence>
<event KT="Other" id="E6">
<type class="Gene_expression"/>
<theme idref="T12"/>
<clue>In the present study we investigated the possible involvement of the mitogen-activated protein kinase family members extracellular-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) in mediating IL-6 gene <clueType>expression</clueType> <clueLoc>in human monocytes</clueLoc>, in particular their role in enhancing NF-kappa B activity.</clue>
</event>
<event KT="Other" id="E7">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<clue>In the present study we investigated the possible involvement of the mitogen-activated protein kinase family members extracellular-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) in <clueType>mediating</clueType> IL-6 gene expression in human monocytes, in particular their role in enhancing NF-kappa B activity.</clue>
</event>
<event KT="Investigation" id="E8" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="T7"/>
<theme idref="E7"/>
<clue>In the present study we <clueKT>investigated</clueKT> the possible <clueType>involvement</clueType> <linkCause>of</linkCause> the mitogen-activated protein kinase family members extracellular-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) in mediating IL-6 gene expression in human monocytes, in particular their role in enhancing NF-kappa B activity.</clue>
</event>
<event KT="Investigation" id="E9" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="T9"/>
<theme idref="E7"/>
<clue>In the present study we <clueKT>investigated</clueKT> the possible <clueType>involvement</clueType> <linkCause>of</linkCause> the mitogen-activated protein kinase family members extracellular-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) in mediating IL-6 gene expression in human monocytes, in particular their role in enhancing NF-kappa B activity.</clue>
</event>
<event KT="Investigation" id="E10" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="T11"/>
<theme idref="E7"/>
<clue>In the present study we <clueKT>investigated</clueKT> the possible <clueType>involvement</clueType> <linkCause>of</linkCause> the mitogen-activated protein kinase family members extracellular-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) in mediating IL-6 gene expression in human monocytes, in particular their role in enhancing NF-kappa B activity.</clue>
</event>
<event KT="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="T16"/>
<clue>In the present study we investigated the possible involvement of the mitogen-activated protein kinase family members extracellular-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) in mediating IL-6 gene expression in human monocytes, in particular their role in <clueType>enhancing</clueType> NF-kappa B activity.</clue>
</event>
<event KT="Investigation" id="E12" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="E11"/>
<theme idref="T7"/>
<clue>In the present study we <clueKT>investigated</clueKT> the possible involvement of the mitogen-activated protein kinase family members extracellular-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) in mediating IL-6 gene expression in human monocytes, in particular <corefCause>their</corefCause> <clueType>role</clueType> <linkTheme>in</linkTheme> enhancing NF-kappa B activity.</clue>
</event>
<event KT="Investigation" id="E13" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="E11"/>
<theme idref="T9"/>
<clue>In the present study we <clueKT>investigated</clueKT> the possible involvement of the mitogen-activated protein kinase family members extracellular-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) in mediating IL-6 gene expression in human monocytes, in particular <corefCause>their</corefCause> <clueType>role</clueType> <linkTheme>in</linkTheme> enhancing NF-kappa B activity.</clue>
</event>
<event KT="Investigation" id="E14" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="E11"/>
<theme idref="T11"/>
<clue>In the present study we <clueKT>investigated</clueKT> the possible involvement of the mitogen-activated protein kinase family members extracellular-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) in mediating IL-6 gene expression in human monocytes, in particular <corefCause>their</corefCause> <clueType>role</clueType> <linkTheme>in</linkTheme> enhancing NF-kappa B activity.</clue>
</event>
<sentence id="S3"><term id="A1" sem="Cell_natural">Freshly isolated monocytes</term> treated with the <term id="T17" lex="protein_phosphatase_inhibitor" sem="Organic_compound_other"><term id="A101" sem="Protein_family_or_group">protein phosphatase</term> inhibitor</term> <term id="T18" lex="okadaic_acid" sem="Organic_compound_other">okadaic acid</term> secreted high levels of <term id="T19" lex="IL-6_protein" sem="Protein_molecule"><term id="T20" lex="IL-6" sem="Protein_molecule">IL-6</term> protein</term>, which coincided with enhanced <term id="T13" sem="Other">binding activity</term> of <term id="T21" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> as well as with <term id="T22" lex="phosphorylation" sem="Other">phosphorylation</term> and <term id="T23" lex="activation" sem="Other">activation</term> of the <cons id="T24" lex="(AND ERK1/2_protein JNK_protein)" sem="(AND Protein_molecule Protein_molecule)"><frag id="F1"><term id="A2" sem="Protein_molecule">ERK</term><term id="A3" sem="Protein_molecule">1</term>/<term id="A4" sem="Protein_molecule">2</term></frag> and <frag id="F2"><term id="A5" sem="Protein_molecule">JNK</term></frag> <frag id="F3">proteins</frag></cons>.</sentence>
<event id="E15">
<type class="Negative_regulation"/>
<theme idref="A101"/>
<cause idref="T18"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase <clueType>inhibitor</clueType> okadaic acid secreted high levels of IL-6 protein, which coincided with enhanced binding activity of NF-kappa B as well as with phosphorylation and activation of the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E16">
<type class="Gene_expression"/>
<theme idref="T19"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid <clueType>secreted</clueType> high levels of IL-6 protein, which coincided with enhanced binding activity of NF-kappa B as well as with phosphorylation and activation of the ERK1/2 and JNK proteins.</clue>
</event>
<event Manner="High" id="E17">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="T18"/>
<clue><clueLoc>Freshly isolated monocytes</clueLoc> <linkCause>treated with</linkCause> the protein phosphatase inhibitor okadaic acid secreted <clueType><clueManner>high levels</clueManner></clueType> <linkTheme>of</linkTheme> IL-6 protein, which coincided with enhanced binding activity of NF-kappa B as well as with phosphorylation and activation of the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E18">
<type class="Binding"/>
<theme idref="T21"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which coincided with enhanced <clueType>binding</clueType> activity <linkTheme>of</linkTheme> NF-kappa B as well as with phosphorylation and activation of the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which coincided with <clueType>enhanced</clueType> binding activity of NF-kappa B as well as with phosphorylation and activation of the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E20">
<type class="Correlation"/>
<theme idref="E17"/>
<theme idref="E19"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which <clueType>coincided</clueType> <linkTheme>with</linkTheme> enhanced binding activity of NF-kappa B as well as with phosphorylation and activation of the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E21">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="A2" idref1="A3"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which coincided with enhanced binding activity of NF-kappa B as well as with <clueType>phosphorylation</clueType> and activation <linkTheme>of</linkTheme> the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E22">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="A2" idref1="A4"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which coincided with enhanced binding activity of NF-kappa B as well as with <clueType>phosphorylation</clueType> and activation <linkTheme>of</linkTheme> the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E23">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="A5"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which coincided with enhanced binding activity of NF-kappa B as well as with <clueType>phosphorylation</clueType> and activation <linkTheme>of</linkTheme> the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="A2" idref1="A3"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which coincided with enhanced binding activity of NF-kappa B as well as with phosphorylation and <clueType>activation</clueType> <linkTheme>of</linkTheme> the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E25">
<type class="Positive_regulation"/>
<theme idref="A2" idref1="A4"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which coincided with enhanced binding activity of NF-kappa B as well as with phosphorylation and <clueType>activation</clueType> <linkTheme>of</linkTheme> the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E26">
<type class="Positive_regulation"/>
<theme idref="A5"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which coincided with enhanced binding activity of NF-kappa B as well as with phosphorylation and <clueType>activation</clueType> <linkTheme>of</linkTheme> the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E27">
<type class="Correlation"/>
<theme idref="E17"/>
<theme idref="E21"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which <clueType>coincided</clueType> with enhanced binding activity of NF-kappa B as well as <linkTheme>with</linkTheme> phosphorylation and activation of the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E28">
<type class="Correlation"/>
<theme idref="E17"/>
<theme idref="E22"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which <clueType>coincided</clueType> with enhanced binding activity of NF-kappa B as well as <linkTheme>with</linkTheme> phosphorylation and activation of the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E29">
<type class="Correlation"/>
<theme idref="E17"/>
<theme idref="E23"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which <clueType>coincided</clueType> with enhanced binding activity of NF-kappa B as well as <linkTheme>with</linkTheme> phosphorylation and activation of the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E30">
<type class="Correlation"/>
<theme idref="E17"/>
<theme idref="E24"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which <clueType>coincided</clueType> with enhanced binding activity of NF-kappa B as well as <linkTheme>with</linkTheme> phosphorylation and activation of the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E31">
<type class="Correlation"/>
<theme idref="E17"/>
<theme idref="E25"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which <clueType>coincided</clueType> with enhanced binding activity of NF-kappa B as well as <linkTheme>with</linkTheme> phosphorylation and activation of the ERK1/2 and JNK proteins.</clue>
</event>
<event id="E32">
<type class="Correlation"/>
<theme idref="E17"/>
<theme idref="E26"/>
<clue>Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which <clueType>coincided</clueType> with enhanced binding activity of NF-kappa B as well as <linkTheme>with</linkTheme> phosphorylation and activation of the ERK1/2 and JNK proteins.</clue>
</event>
<sentence id="S4">The <term id="T25" lex="ERK_pathway-specific_inhibitor" sem="Organic_compound_other">ERK pathway-specific inhibitor</term> <term id="T26" lex="PD98059" sem="Organic_compound_other">PD98059</term> inhibited <term id="T27" lex="IL-6_secretion" sem="Other"><term id="T28" lex="IL-6" sem="Protein_molecule">IL-6</term> secretion</term> from <term id="T29" lex="monocyte" sem="Cell_natural">monocytes</term>.</sentence>
<event KT="Other" id="E33">
<type class="Localization"/>
<theme idref="T28"/>
<clue>The ERK pathway-specific inhibitor PD98059 inhibited IL-6 <clueType>secretion</clueType> <clueLoc>from monocytes</clueLoc>.</clue>
</event>
<event id="E34">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T26"/>
<clue>The ERK pathway-specific inhibitor PD98059 <clueType>inhibited</clueType> IL-6 secretion from monocytes.</clue>
</event>
<sentence id="S5">Transient overexpression of <term id="A8" sem="Protein_molecule">inactive mutants of</term> either <term id="T30" lex="Raf-1" sem="Protein_molecule">Raf-1</term> or <term id="T31" lex="JNK1" sem="Protein_molecule">JNK1</term> showed that both pathways were involved in <term id="A6" sem="DNA_domain_or_region">kappa B</term>-dependent <term id="T330" sem="Other"><term id="A7" sem="DNA_domain_or_region"><term id="T33" lex="IL-6" sem="Protein_molecule">IL-6</term> promoter</term> activity</term>.</sentence>
<event KT="Other" id="E35">
<type class="Gene_expression"/>
<theme idref="A8" idref1="T30"/>
<clue>Transient <clueType>overexpression</clueType> <linkTheme>of</linkTheme> inactive mutants of either Raf-1 or JNK1 showed that both pathways were involved in kappa B-dependent IL-6 promoter activity.</clue>
</event>
<event KT="Other" id="E36">
<type class="Gene_expression"/>
<theme idref="A8" idref1="T31"/>
<clue>Transient <clueType>overexpression</clueType> <linkTheme>of</linkTheme> inactive mutants of either Raf-1 or JNK1 showed that both pathways were involved in kappa B-dependent IL-6 promoter activity.</clue>
</event>
<event KT="Other" id="E37">
<type class="Positive_regulation"/>
<theme idref="E35"/>
<clue>Transient <clueType>overexpression</clueType> of inactive mutants of either Raf-1 or JNK1 showed that both pathways were involved in kappa B-dependent IL-6 promoter activity.</clue>
</event>
<event KT="Other" id="E38">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<clue>Transient <clueType>overexpression</clueType> of inactive mutants of either Raf-1 or JNK1 showed that both pathways were involved in kappa B-dependent IL-6 promoter activity.</clue>
</event>
<event KT="Other" id="E39">
<type class="Regulation"/>
<theme idref="A7"/>
<cause idref="A6"/>
<clue>Transient overexpression of inactive mutants of either Raf-1 or JNK1 showed that both pathways were involved in kappa B-<clueType>dependent</clueType> IL-6 promoter activity.</clue>
</event>
<event KT="Analysis" id="E40">
<type class="Correlation"/>
<theme idref="T30"/>
<theme idref="E39"/>
<clue>Transient overexpression of inactive mutants of either Raf-1 or JNK1 <clueKT>showed</clueKT> that <corefTheme>both pathways</corefTheme> were <clueType>involved</clueType> <linkTheme>in</linkTheme> kappa B-dependent IL-6 promoter activity.</clue>
</event>
<event KT="Analysis" id="E41">
<type class="Correlation"/>
<theme idref="T31"/>
<theme idref="E39"/>
<clue>Transient overexpression of inactive mutants of either Raf-1 or JNK1 <clueKT>showed</clueKT> that <corefTheme>both pathways</corefTheme> were <clueType>involved</clueType> <linkTheme>in</linkTheme> kappa B-dependent IL-6 promoter activity.</clue>
</event>
<sentence id="S6">By using <term id="T34" lex="PD98059" sem="Organic_compound_other">PD98059</term>, we demonstrated that the <term id="T35" lex="Raf1/MEK1/ERK1/2_pathway" sem="Other"><term id="A9" sem="Protein_molecule">Raf1</term>/<term id="A10" sem="Protein_molecule">MEK1</term>/<term id="T36" lex="ERK1/2" sem="Protein_molecule">ERK1/2</term> pathway</term> did not affect the <term id="T32" sem="Other"><term id="A11" sem="DNA_domain_or_region">DNA</term> binding</term> of <term id="T37" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> but, rather, acted at the level of <term id="T38" lex="transcriptional_activity" sem="Other">transcriptional activity</term> of <term id="T39" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>.</sentence>
<event KT="Other" id="E42">
<type class="Binding"/>
<theme idref="A11"/>
<theme idref="T37"/>
<clue>By using PD98059, we demonstrated that the Raf1/MEK1/ERK1/2 pathway did not affect the DNA <clueType>binding</clueType> <linkTheme>of</linkTheme> NF-kappa B but, rather, acted at the level of transcriptional activity of NF-kappa B.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E43">
<type class="Regulation"/>
<theme idref="E42"/>
<cause idref="T35"/>
<clue>By using PD98059, we <clueKT>demonstrated</clueKT> that the Raf1/MEK1/ERK1/2 pathway did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the DNA binding of NF-kappa B but, rather, acted at the level of transcriptional activity of NF-kappa B.</clue>
</event>
<event KT="Analysis" id="E44">
<type class="Regulation"/>
<theme idref="T39"/>
<cause idref="T35"/>
<clue>By using PD98059, we <clueKT>demonstrated</clueKT> that the Raf1/MEK1/ERK1/2 pathway did not affect the DNA binding of NF-kappa B but, rather, <clueType>acted</clueType> <linkTheme>at</linkTheme> the level of transcriptional activity of NF-kappa B.</clue>
</event>
<sentence id="S7">Interestingly, it was shown that <term id="T41" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>-mediated <term id="A12" sem="Other">gene transcription</term>, both in the context of the <term id="T42" lex="IL-6_promoter" sem="DNA_domain_or_region"><term id="T43" lex="IL-6" sem="Protein_molecule">IL-6</term> promoter</term> as well as on its own, was dependent on both <term id="T44" lex="serine_kinase_activity" sem="Other"><term id="A13" sem="Protein_molecule"><term id="T45" lex="serine" sem="Amino_acid_monomer">serine</term> kinase</term> activity</term> and interaction with <term id="T46" lex="c-Jun_protein" sem="Protein_molecule">c-Jun protein</term>.</sentence>
<event KT="Other" id="E45">
<type class="Positive_regulation"/>
<theme idref="A12"/>
<cause idref="T41"/>
<clue>Interestingly, it was shown that NF-kappa B-<clueType>mediated</clueType> gene transcription, both in the context of the IL-6 promoter as well as on its own, was dependent on both serine kinase activity and interaction with c-Jun protein.</clue>
</event>
<event KT="Analysis" id="E46">
<type class="Positive_regulation"/>
<theme idref="E45"/>
<cause idref="A13"/>
<clue>Interestingly, it was <clueKT>shown</clueKT> that NF-kappa B-mediated gene transcription, both in the context of the IL-6 promoter as well as on its own, was <clueType>dependent</clueType> <linkCause>on</linkCause> both serine kinase activity and interaction with c-Jun protein.</clue>
</event>
<event KT="Other" id="E47">
<type class="Binding"/>
<theme idref="T46"/>
<clue>Interestingly, it was shown that NF-kappa B-mediated gene transcription, both in the context of the IL-6 promoter as well as on its own, was dependent on both serine kinase activity and <clueType>interaction</clueType> <linkTheme>with</linkTheme> c-Jun protein.</clue>
</event>
<event KT="Analysis" id="E48">
<type class="Positive_regulation"/>
<theme idref="E45"/>
<cause idref="E47"/>
<clue>Interestingly, it was <clueKT>shown</clueKT> that NF-kappa B-mediated gene transcription, both in the context of the IL-6 promoter as well as on its own, was <clueType>dependent</clueType> <linkCause>on</linkCause> both serine kinase activity and interaction with c-Jun protein.</clue>
</event>
<event KT="Other" id="E80">
<type class="Transcription"/>
<theme idref="T42"/>
<clue>Interestingly, it was shown that NF-kappa B-mediated gene <clueType>transcription</clueType>, both <linkTheme>in the context of</linkTheme> the IL-6 promoter as well as on its own, was dependent on both serine kinase activity and interaction with c-Jun protein.</clue>
</event>
<event KT="Analysis" id="E81">
<type class="Positive_regulation"/>
<theme idref="E80"/>
<cause idref="A13"/>
<clue>Interestingly, it was <clueKT>shown</clueKT> that NF-kappa B-mediated gene transcription, both in the context of the IL-6 promoter as well as on its own, was <clueType>dependent</clueType> <linkCause>on</linkCause> both serine kinase activity and interaction with c-Jun protein.</clue>
</event>
<event KT="Analysis" id="E82">
<type class="Positive_regulation"/>
<theme idref="E80"/>
<cause idref="E47"/>
<clue>Interestingly, it was <clueKT>shown</clueKT> that NF-kappa B-mediated gene transcription, both in the context of the IL-6 promoter as well as on its own, was <clueType>dependent</clueType> <linkCause>on</linkCause> both serine kinase activity and interaction with c-Jun protein.</clue>
</event>
<sentence id="S8">We conclude that <term id="T49" lex="okadaic_acid" sem="Organic_compound_other">okadaic acid</term>-induced <term id="T40" sem="Other"><term id="T50" lex="IL-6" sem="DNA_domain_or_region">IL-6 gene</term> expression</term> is at least partly mediated through the <cons id="C1" lex="(AND ERK1/2_pathway JNK_pathway)" sem="(AND Other Other)"><frag id="F4"><term id="T52" lex="ERK1/2" sem="Protein_molecule">ERK1/2</term></frag> and <term id="T53" lex="JNK" sem="Protein_molecule"><frag id="F5">JNK</frag></term> <frag id="F6">pathway</frag></cons>-dependent <term id="T54" lex="activation" sem="Other">activation</term> of <term id="T47" sem="Other"><term id="T55" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> transcriptional capacity</term>.</sentence>
<event KT="Other" id="E50">
<type class="Gene_expression"/>
<theme idref="T50"/>
<clue>We conclude that okadaic acid-induced IL-6 gene <clueType>expression</clueType> is at least partly mediated through the ERK1/2 and JNK pathway-dependent activation of NF-kappa B transcriptional capacity.</clue>
<comment>NER T50,T51 MOD</comment></event>
<event KT="Other" id="E150">
<type class="Positive_regulation"/>
<theme idref="E50"/>
<cause idref="T49"/>
<clue>We conclude that okadaic acid-<clueType>induced</clueType> IL-6 gene expression is at least partly mediated through the ERK1/2 and JNK pathway-dependent activation of NF-kappa B transcriptional capacity.</clue>
</event>
<event KT="Other" id="E51">
<type class="Positive_regulation"/>
<theme idref="E45"/>
<cause idref="F4" idref1="F6"/>
<clue>We conclude that okadaic acid-induced IL-6 gene expression is at least partly mediated through the ERK1/2 and JNK pathway-<linkCause>dependent</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> <corefTheme>NF-kappa B transcriptional capacity</corefTheme>.</clue>
</event>
<event KT="Other" id="E52">
<type class="Positive_regulation"/>
<theme idref="E45"/>
<cause idref="F5" idref1="F6"/>
<clue>We conclude that okadaic acid-induced IL-6 gene expression is at least partly mediated through the ERK1/2 and JNK pathway-<linkCause>dependent</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> <corefTheme>NF-kappa B transcriptional capacity</corefTheme>.</clue>
</event>
<event KT="Analysis" id="E53">
<type class="Positive_regulation"/>
<theme idref="E150"/>
<cause idref="E51"/>
<clue>We <clueKT>conclude</clueKT> that okadaic acid-induced IL-6 gene expression is at least partly <clueType>mediated</clueType> <linkCause>through</linkCause> the ERK1/2 and JNK pathway-dependent activation of NF-kappa B transcriptional capacity.</clue>
</event>
<event KT="Analysis" id="E153">
<type class="Positive_regulation"/>
<theme idref="E150"/>
<cause idref="E52"/>
<clue>We <clueKT>conclude</clueKT> that okadaic acid-induced IL-6 gene expression is at least partly <clueType>mediated</clueType> <linkCause>through</linkCause> the ERK1/2 and JNK pathway-dependent activation of NF-kappa B transcriptional capacity.</clue>
</event>
<sentence id="S9">Our results suggest that the <term id="T57" lex="JNK_pathway" sem="Other"><term id="T58" lex="JNK" sem="Protein_molecule">JNK</term> pathway</term> may regulate <term id="T60" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>-mediated <term id="T48" sem="Other">gene transcription</term> through its <term id="T61" lex="phosphorylation" sem="Other">phosphorylation</term> and <term id="T62" lex="activation" sem="Other">activation</term> of <term id="T63" lex="c-Jun" sem="Protein_molecule">c-Jun</term>.</sentence>
<event KT="Other" id="E54">
<type class="Positive_regulation"/>
<theme idref="T48"/>
<cause idref="T60"/>
<clue>Our results suggest that the JNK pathway may regulate NF-kappa B-<clueType>mediated</clueType> gene transcription through its phosphorylation and activation of c-Jun.</clue>
</event>
<event KT="Other" id="E55">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T63"/>
<cause idref="T58"/>
<clue>Our results suggest that the JNK pathway may regulate NF-kappa B-mediated gene transcription through <corefCause>its</corefCause> <clueType>phosphorylation</clueType> and activation <linkTheme>of</linkTheme> c-Jun.</clue>
</event>
<event CL="L1" KT="Analysis" id="E56" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E54"/>
<cause idref="E55"/>
<clue>Our results <clueKT>suggest</clueKT> that the JNK pathway <clueCL>may</clueCL> <clueType>regulate</clueType> NF-kappa B-mediated gene transcription <linkCause>through</linkCause> its phosphorylation and activation of c-Jun.</clue>
</event>
<event KT="Other" id="E57">
<type class="Positive_regulation"/>
<theme idref="T63"/>
<cause idref="T58"/>
<clue>Our results suggest that the JNK pathway may regulate NF-kappa B-mediated gene transcription through <corefCause>its</corefCause> phosphorylation and <clueType>activation</clueType> <linkTheme>of</linkTheme> c-Jun.</clue>
</event>
<event CL="L1" KT="Analysis" id="E58" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E54"/>
<cause idref="E57"/>
<clue>Our results <clueKT>suggest</clueKT> that the JNK pathway <clueCL>may</clueCL> <clueType>regulate</clueType> NF-kappa B-mediated gene transcription <linkCause>through</linkCause> its phosphorylation and activation of c-Jun.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
